Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan-Reference-Cited by-同舟云学术

Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan

Published:2023-11 Issue:47 Volume:41 Page:6969-6979
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Arashiro Takeshi^ORCID,Arima Yuzo,Kuramochi Jin,Muraoka Hirokazu,Sato Akihiro,Chubachi Kumi,Oba Kunihiro,Yanai Atsushi,Arioka Hiroko,Uehara Yuki,Ihara Genei,Kato Yasuyuki,Yanagisawa Naoki,Nagura Yoshito,Yanai Hideki^ORCID,Ueda Akihiro,Numata Akira,Kato Hideaki^ORCID,Oka Hideaki,Nishida Yusuke,Ishii Koji,Ooki Takao,Nidaira Yuki,Asami Takahiro,Jinta Torahiko,Nakamura Akira,Taniyama Daisuke,Yamamoto Kei,Tanaka Katsushi,Ueshima Kankuro,Fuwa Tetsuji,Stucky Ashley^ORCID,Suzuki Tadaki,Smith Chris^ORCID,Hibberd Martin^ORCID,Ariyoshi Koya,Suzuki Motoi

Funder

Ministry of Health, Labour and Welfare

Japan Agency for Medical Research and Development

Nagasaki University

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference46 articles.

1. Coronavirus disease (COVID-19) pandemic. World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

2. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

3. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

4. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting;Dagan;N Engl J Med,2021

5. Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants;Journal of Infection;2024-10

2. Factors affecting motivation for receiving a booster dose of the COVID-19 vaccine among Japanese university students and staff: a cross-sectional questionnaire survey;Scientific Reports;2024-04-05

3. Bivalent COVID-19 vaccines boost the capacity of pre-existing SARS-CoV-2-specific memory B cells to cross-recognize Omicron subvariants;2024-03-22

4. Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection;Viruses;2024-03-08